Skip to main
MXL
MXL logo

MaxLinear (MXL) Stock Forecast & Price Target

MaxLinear (MXL) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 43%
Buy 14%
Hold 43%
Sell 0%
Strong Sell 0%

Bulls say

MaxLinear Inc. has shown a robust sales outlook for the upcoming quarter, projecting $125 million in revenue, which surpasses market expectations by 8% and reflects a 15% quarter-over-quarter growth. Additionally, projections for fiscal year 2026 indicate a revenue increase to $540 million from $531 million, maintaining earnings per share at $0.90 despite some foreign exchange pressures. The company is also benefiting from a recovery in end markets and acceleration in new product momentum, highlighting a strong fundamental outlook.

Bears say

The financial outlook for MaxLinear Inc is negatively impacted by potential revenue reductions stemming from uncertainties surrounding the adoption rate of its PAM4 solution, which could lead to lower earnings estimates if market uptake is slower than anticipated. Additionally, foreign exchange fluctuations have adversely affected earnings by approximately $4.4 million, translating to a reduction of about $0.05 per share, further illustrating the financial vulnerabilities the company faces. Overall, these challenges collectively contribute to a cautious viewpoint regarding MaxLinear's future revenue growth and earnings performance.

MaxLinear (MXL) has been analyzed by 7 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 14% recommend Buy, 43% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of MaxLinear and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About MaxLinear (MXL) Forecast

Analysts have given MaxLinear (MXL) a Buy based on their latest research and market trends.

According to 7 analysts, MaxLinear (MXL) has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.93, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.93, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

MaxLinear (MXL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.